These reductions in plasma glucose and/or insulin concentrations inhibited tumor glucose uptake: chronic dapagliflozin treatment lowered MMTV-PyMT tumor [14C] 2-deoxyglucose uptake, more markedly than did acute treatment (Fig. 2e). Here, INS is linked to neoplasm.